LONDON - Monday, May 26th 2014 [ME NewsWire]
(BUSINESS WIRE) The GSMA today announced that senior leaders from nine major mobile operator groups, accounting for over half a billion mobile connections across 48 countries in Africa and the Middle East, are individually undertaking initiatives designed to reduce the cost of roaming for consumers across both regions. The nine operator groups are committed to a range of roaming initiatives that, in addition to addressing pricing, will improve regional connectivity and mobility by increasing roaming footprints to provide greater customer choice, with a particular focus on improving routes for pre-paid customers. These combined efforts will enable consumers in Africa and the Middle East to use their mobile phones with greater confidence and predictability whilst travelling.
“International and regional mobility is a critical factor in increasing trade and cross-border economic cooperation, which is a government priority across Africa and the Middle East,” said Anne Bouverot, Director General, GSMA. “The initiatives of these nine operators are intended to serve to increase connectivity and make mobile more affordable for subscribers throughout these regions, encouraging greater adoption and usage of mobile services and enabling important socio-economic benefits.”
As part of their work, the operators will look at a range of factors that affect roaming prices, with the aim of improving technical efficiencies and reducing costs. The senior leaders from the nine mobile operator groups supporting these initiatives are:
Christian de Faria, CEO Africa, Bharti Airtel
Ahmad Julfar, Group CEO, Etisalat Group
Arthur Bastings, EVP Africa, Millicom
Sifiso Dabengwa, CEO and President, MTN Group
Dr. Nasser Marafih, Group CEO, Ooredoo Group
Marc Rennard, Senior Executive Vice President, Africa, Middle East and Asia, Orange
Abdulaziz A. Alsugair, Chairman and Managing Director, STC Group
Serpil Timuray, CEO, Africa, Middle East and Asia Pacific Region, Vodafone Group
Scott Gegenheimer, CEO, Zain Group
GSMA research has shown emerging markets, including many countries in Africa and the Middle East, are now the major engines of mobile connection and subscriber growth. The rapidly increasing pace of mobile adoption has delivered huge economic benefits for the regions, with the mobile industry directly contributing US $60 billion to the sub-Saharan African economy, or six per cent of GDP and US $132 billion to the economies of the Arab States, or approximately 5.5 per cent of total GDP.
Bouverot continued, “Mobile is focused on connecting the billions of unconnected around the world, providing access to critical communications, information and services and offering new economic opportunities. Market dynamics are delivering more affordable roaming prices and better value for consumers. Within both regions this will be driven in particular by the move from voice to more price elastic data usage.”
-ENDS-
Notes to Editors
Unless otherwise stated, market data is sourced from GSMA reports including The Arab States Mobile Observatory: http://www.gsma.com/publicpolicy/wp-content/uploads/2012/03/GSMA_MobileObservatory_ArabStates2013.pdf and Mobile Economy Sub-Saharan Africa Report 2013 http://www.gsma.com/newsroom/gsma-mobile-economy-sub-saharan-africa-report-2013/#.U0bZn_ldV40
About the GSMA
The GSMA represents the interests of mobile operators worldwide. Spanning more than 220 countries, the GSMA unites nearly 800 of the world’s mobile operators with more than 250 companies in the broader mobile ecosystem, including handset makers, software companies, equipment providers and Internet companies, as well as organisations in industry sectors such as financial services, healthcare, media, transport and utilities. The GSMA also produces industry-leading events such as the Mobile World Congress and Mobile Asia Expo.
For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.
Contacts
For the GSMA
Charlie Meredith-Hardy
+44 7917 298428
CMeredith-Hardy@webershandwick.com
GSMA Press Office
press@gsma.com
Permalink: http://www.me-newswire.net/news/11092/en
Wednesday, May 28, 2014
The GSMA: Operators to Reduce Roaming Costs Across Africa and Middle East
Posted by
Business Daily Africa
Champions League Final Activities Kick off in Lisbon
LISBON, Portugal - Wednesday, May 21st 2014 [ME NewsWire]
(BUSINESS WIRE)-- UEFA Champions League Final activities kicked off today in Lisbon as UEFA handed over a maxi pitch to the city, to be used for grass-roots football activities. Maniche, former Portugal international, was on hand to coach a group of local children during the first match played on the pitch, located in Clube Oriental de Lisboa’s premises.
“It’s great to see that Lisbon is hosting the UEFA Champions League final and the UEFA Womens’ Champions League final. With the inauguration of the maxi pitch UEFA shows they are not just interested in staging big events. UEFA is ensuring that football is a sport for everyone, from the stars who will play at the Estádio do Sport Lisboa e Benfica to the local kids who will come here and play with their friends” said Maniche.
UEFA Champions League activities continue tomorrow with the opening of the UEFA Champions League Festival, located in Praça do Comércio, Lisbon’s main square. The Festival, which runs until 25 May, is a free event featuring a range of activities and exhibitions.
UEFA is inviting fans and families to visit and take part in the activities, including the opportunity to have photos taken with the UEFA Champions League and UEFA Women's Champions League trophies.
Other highlights include the UEFA Champions League Museum and UEFA Champions Gallery (open daily from 10.00–20.30 until 25 May), the open-air cinema showing the world premiere of the Champions League film, and the Ultimate Champions Match on Friday 23 May.
The UEFA Women’s Champions League final also takes place on Thursday 22 May at 19h30 GMT. The final, which opposes defending champions VfL Wolfsburg and Sweden’s Tyresö FF, will be played at Estádio do Restelo in Lisbon. The final match includes performances by international R&B star Anselmo Ralph.
More information on www.uefa.com
Contacts
UEFA
Press contact:
Francisco Empis, Tel: +351913089871
fe@cunhavaz.com
Permalink: http://www.me-newswire.net/news/11062/en
(BUSINESS WIRE)-- UEFA Champions League Final activities kicked off today in Lisbon as UEFA handed over a maxi pitch to the city, to be used for grass-roots football activities. Maniche, former Portugal international, was on hand to coach a group of local children during the first match played on the pitch, located in Clube Oriental de Lisboa’s premises.
“It’s great to see that Lisbon is hosting the UEFA Champions League final and the UEFA Womens’ Champions League final. With the inauguration of the maxi pitch UEFA shows they are not just interested in staging big events. UEFA is ensuring that football is a sport for everyone, from the stars who will play at the Estádio do Sport Lisboa e Benfica to the local kids who will come here and play with their friends” said Maniche.
UEFA Champions League activities continue tomorrow with the opening of the UEFA Champions League Festival, located in Praça do Comércio, Lisbon’s main square. The Festival, which runs until 25 May, is a free event featuring a range of activities and exhibitions.
UEFA is inviting fans and families to visit and take part in the activities, including the opportunity to have photos taken with the UEFA Champions League and UEFA Women's Champions League trophies.
Other highlights include the UEFA Champions League Museum and UEFA Champions Gallery (open daily from 10.00–20.30 until 25 May), the open-air cinema showing the world premiere of the Champions League film, and the Ultimate Champions Match on Friday 23 May.
The UEFA Women’s Champions League final also takes place on Thursday 22 May at 19h30 GMT. The final, which opposes defending champions VfL Wolfsburg and Sweden’s Tyresö FF, will be played at Estádio do Restelo in Lisbon. The final match includes performances by international R&B star Anselmo Ralph.
More information on www.uefa.com
Contacts
UEFA
Press contact:
Francisco Empis, Tel: +351913089871
fe@cunhavaz.com
Permalink: http://www.me-newswire.net/news/11062/en
Posted by
Business Daily Africa
Octapharma Sponsors Symposium “Spotlight on the Human Factor: Building a Foundation for the Future of Haemophilia A Management" at 2014 WFH World Congress in Melbourne, Australia
LACHEN, Switzerland. - Tuesday, May 27th 2014 [ME NewsWire]
(BUSINESS WIRE) Octapharma sponsored the symposium "Spotlight on the human factor: building a foundation for the future of haemophilia A management" during the World Federation of Hemophilia (WFH) World Congress in Melbourne, Australia on Monday May 12th 2014.
Major challenges in current haemophilia treatment include the development of inhibitors and the need for frequent venous access for FVIII injection. Octapharma’s human cell line recombinant FVIII (Human-cl rhFVIII) is a new- generation rFVIII derived from a human cell line without addition of animal derived proteins. Human-cl rhFVIII is a glycoprotein devoid of antigenic non-human epitopes. The development aim of Human-cl rhFVIII is to address the challenges of FVIII inhibitors and frequent infusions required during prophylaxis.
On May 22nd, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorisation for the medicinal product Nuwiq®, intended for treatment and prophylaxis of bleeding in paediatric and adult patients with haemophilia A (congenital factor VIII deficiency).
Data for the product has also been submitted to authorities in Canada and Australia, with further worldwide submissions planned.
Presented during the symposium were the results of the recently completed multicenter clinical trials, which assessed the safety, pharmacokinetics, efficacy and immunogenicity of Human-cl rhFVIII in children and adults with severe haemophilia A. In addition, insights into the ongoing previously untreated patient (PUP) study, NuProtect, and the new personalised prophylaxis study, NuPreviq, were presented.
The symposium was co-chaired by Johannes Oldenburg, Chairman and Director of the Institute of Experimental Haematology and Transfusion Medicine and of the Haemophilia Center, University Clinic Bonn, and Craig M. Kessler, attending haematologist/oncologist and Professor of Medicine, Pathology, and Oncology at the Vincent Lombardi Comprehensive Cancer Center at Georgetown University Medical Center in Washington, D.C.
Craig Kessler opened the symposium by presenting unmet clinical needs in haemophilia care including the high risk of inhibitor development in PUPs and the development of new inhibitors throughout the lifetime of previously treated patients (PTPs). He mentioned that “one-size-fits-all” strategy for prophylaxis may pose an unnecessary bleeding risk to patients. A tailored dosing approach is desirable to ensure a high quality of life because of differences in FVIII half lives between patients. Dr. Kessler also highlighted that inhibitor rates are currently unknown for new- generation, artificially enlarged, rFVIII products, as are the potential considerations for product-specific assays of some novel rFVIIIs .
Current rFVIII products produced in hamster cell lines are associated with a cumulative incidence of inhibitors of up to 38% in PUPs. The recruitment rate for the ongoing NuProtect study has been high. Kate Khair, Nurse Consultant at Great Ormond Street Children’s Hospital London, presented “The NuProtect study: can inhibitor incidence in PUPs be reduced?” This study in unselected PUPs aims to differentiate Human-cl rhFVIII with a potentially reduced rate of inhibitors in all ethnic groups. So far, 33 patients have been screened and 24 have started treatment. Optional satellite studies aim to identify predictive markers of inhibitor development in order to identify individuals at increased risk of inhibitor formation.
Carmen Escuriola-Ettingshausen from the Hämophilie-Zentrum Rhein Main (HZRM), Mörfelden-Frankfurt, Germany, presented “Inhibitors in haemophilia: perspectives and challenges”. Octanate is a human plasma-derived FVIII naturally stabilised with von Willebrand factor (VWF) and is a fully sulfated protein. The incidence of clinically relevant inhibitors in an ongoing study in PUPs is 5.9% (3/51). Successful immune tolerance induction was demonstrated with >70% of octanate® patients (many poor prognosis) from the ongoing Observational Immune Tolerance Induction (ObsITI) study.
Dr. Escuriola- Ettinhausen further presented biochemical characteristics of Human-cl rh FVIII. Human-cl rh FVIII is also a fully sulfated human protein. It has significantly higher VWF binding affinity compared with existing full-length rFVIII produced in hamster cell lines. No product specific assay is required for Human-cl rhFVIII as has been shown by consistent results across assays.
Human-cl rhFVIII has completed its clinical development program in accordance with regulatory requirements in paediatric, adolescent and adult PTPs. Andreas Tiede, Head of the Haemophilia Care Centre at Hannover Medical School, Hannover, Germany, presented “The new Human-cl rhFVIII: overview of clinical trial experience in children and adults with haemophilia A”. Dr. Tiede presented that 96.7% of bleeds were controlled with one or two infusions (adults on-demand); mean ABR (annual bleeding rate; spontaneous bleeds) was 1.5 in paediatric and 1.2 in adult patients on prophylaxis and no inhibitors were reported in 135 PTPs treated so far (200 PTPs including NuPreviq). No drug-related serious or severe adverse events have been reported.
Individualisation of therapy is likely to play a major role in the near future of treatment. Claude Négrier, Head of the Haematology Department at Edouard Herriot University Hospital in Lyon, France and also Director of the Haemophilia Comprehensive Care Centre at the same institution, presented “Potential role of TGA in personalized prophylaxis”. Dr. Négrier highlighted that thrombin generation assay (TGA) reflects the bleeding phenotype and might represent a common marker for improvement/achievement of haemostasis. TGA may offer new possibilities to tailor the FVIII dose according to the patient’s haemostatic response.
Human-cl rhFVIII aims to provide patients with fewer infusions during personalized prophylactic treatment. Robert Klamroth, a specialist in internal medicine and coagulation disorders and Director of the Haemophilia Treatment Centre and the Department of Coagulation Disorders at the Vivantes Hospital in Berlin, presented “The NuPreviq study: Human-cl rhFVIII in a multicentre clinical study for personalized prophylaxis”. The ongoing NuPreviq study has enrolled 68 adult patients. Preliminary data in 24 patients indicate a median dosing interval of 3.5 days with 66.7% of patients on a twice-per-week or less infusion schedule with Human-cl rhFVIII. The potential prolonged dosing interval is without increased FVIII consumption when compared to standard prophylaxis. So far, no bleeding episodes have been reported in these 24 patients.
About Haemophilia A
Haemophilia A is an X-linked hereditary disorder caused by factor VIII (FVIII) deficiency which if left untreated leads to haemorrhages in muscles and joints and consequently to arthropathy and severe morbidity. FVIII replacement prophylactic treatment reduces the number of bleeding episodes and the risk of permanent joint damage. This disorder affects one in every 5,000 to 10,000 men worldwide. Globally, 75% of haemophilia cases are left undiagnosed or untreated. The development of neutralising FVIII antibodies (FVIII inhibitors) against infused FVIII represents the most serious treatment complication. The cumulative risk of FVIII inhibitor development is reported to be currently up to 38%.
About Octapharma AG
Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 30 years. Its core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the following therapeutic areas:
Haematology (coagulation disorders)
Immunotherapy (immune disorders)
Critical Care
Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.
For more information visit www.octapharma.com
Contacts
Octapharma AG
Corporate Communications
Claudie Qumsieh
Tel.: +(41)-55-451-21-78
claudie.qumsieh@octapharma.com
Permalink: http://me-newswire.net/news/11109/en
(BUSINESS WIRE) Octapharma sponsored the symposium "Spotlight on the human factor: building a foundation for the future of haemophilia A management" during the World Federation of Hemophilia (WFH) World Congress in Melbourne, Australia on Monday May 12th 2014.
Major challenges in current haemophilia treatment include the development of inhibitors and the need for frequent venous access for FVIII injection. Octapharma’s human cell line recombinant FVIII (Human-cl rhFVIII) is a new- generation rFVIII derived from a human cell line without addition of animal derived proteins. Human-cl rhFVIII is a glycoprotein devoid of antigenic non-human epitopes. The development aim of Human-cl rhFVIII is to address the challenges of FVIII inhibitors and frequent infusions required during prophylaxis.
On May 22nd, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorisation for the medicinal product Nuwiq®, intended for treatment and prophylaxis of bleeding in paediatric and adult patients with haemophilia A (congenital factor VIII deficiency).
Data for the product has also been submitted to authorities in Canada and Australia, with further worldwide submissions planned.
Presented during the symposium were the results of the recently completed multicenter clinical trials, which assessed the safety, pharmacokinetics, efficacy and immunogenicity of Human-cl rhFVIII in children and adults with severe haemophilia A. In addition, insights into the ongoing previously untreated patient (PUP) study, NuProtect, and the new personalised prophylaxis study, NuPreviq, were presented.
The symposium was co-chaired by Johannes Oldenburg, Chairman and Director of the Institute of Experimental Haematology and Transfusion Medicine and of the Haemophilia Center, University Clinic Bonn, and Craig M. Kessler, attending haematologist/oncologist and Professor of Medicine, Pathology, and Oncology at the Vincent Lombardi Comprehensive Cancer Center at Georgetown University Medical Center in Washington, D.C.
Craig Kessler opened the symposium by presenting unmet clinical needs in haemophilia care including the high risk of inhibitor development in PUPs and the development of new inhibitors throughout the lifetime of previously treated patients (PTPs). He mentioned that “one-size-fits-all” strategy for prophylaxis may pose an unnecessary bleeding risk to patients. A tailored dosing approach is desirable to ensure a high quality of life because of differences in FVIII half lives between patients. Dr. Kessler also highlighted that inhibitor rates are currently unknown for new- generation, artificially enlarged, rFVIII products, as are the potential considerations for product-specific assays of some novel rFVIIIs .
Current rFVIII products produced in hamster cell lines are associated with a cumulative incidence of inhibitors of up to 38% in PUPs. The recruitment rate for the ongoing NuProtect study has been high. Kate Khair, Nurse Consultant at Great Ormond Street Children’s Hospital London, presented “The NuProtect study: can inhibitor incidence in PUPs be reduced?” This study in unselected PUPs aims to differentiate Human-cl rhFVIII with a potentially reduced rate of inhibitors in all ethnic groups. So far, 33 patients have been screened and 24 have started treatment. Optional satellite studies aim to identify predictive markers of inhibitor development in order to identify individuals at increased risk of inhibitor formation.
Carmen Escuriola-Ettingshausen from the Hämophilie-Zentrum Rhein Main (HZRM), Mörfelden-Frankfurt, Germany, presented “Inhibitors in haemophilia: perspectives and challenges”. Octanate is a human plasma-derived FVIII naturally stabilised with von Willebrand factor (VWF) and is a fully sulfated protein. The incidence of clinically relevant inhibitors in an ongoing study in PUPs is 5.9% (3/51). Successful immune tolerance induction was demonstrated with >70% of octanate® patients (many poor prognosis) from the ongoing Observational Immune Tolerance Induction (ObsITI) study.
Dr. Escuriola- Ettinhausen further presented biochemical characteristics of Human-cl rh FVIII. Human-cl rh FVIII is also a fully sulfated human protein. It has significantly higher VWF binding affinity compared with existing full-length rFVIII produced in hamster cell lines. No product specific assay is required for Human-cl rhFVIII as has been shown by consistent results across assays.
Human-cl rhFVIII has completed its clinical development program in accordance with regulatory requirements in paediatric, adolescent and adult PTPs. Andreas Tiede, Head of the Haemophilia Care Centre at Hannover Medical School, Hannover, Germany, presented “The new Human-cl rhFVIII: overview of clinical trial experience in children and adults with haemophilia A”. Dr. Tiede presented that 96.7% of bleeds were controlled with one or two infusions (adults on-demand); mean ABR (annual bleeding rate; spontaneous bleeds) was 1.5 in paediatric and 1.2 in adult patients on prophylaxis and no inhibitors were reported in 135 PTPs treated so far (200 PTPs including NuPreviq). No drug-related serious or severe adverse events have been reported.
Individualisation of therapy is likely to play a major role in the near future of treatment. Claude Négrier, Head of the Haematology Department at Edouard Herriot University Hospital in Lyon, France and also Director of the Haemophilia Comprehensive Care Centre at the same institution, presented “Potential role of TGA in personalized prophylaxis”. Dr. Négrier highlighted that thrombin generation assay (TGA) reflects the bleeding phenotype and might represent a common marker for improvement/achievement of haemostasis. TGA may offer new possibilities to tailor the FVIII dose according to the patient’s haemostatic response.
Human-cl rhFVIII aims to provide patients with fewer infusions during personalized prophylactic treatment. Robert Klamroth, a specialist in internal medicine and coagulation disorders and Director of the Haemophilia Treatment Centre and the Department of Coagulation Disorders at the Vivantes Hospital in Berlin, presented “The NuPreviq study: Human-cl rhFVIII in a multicentre clinical study for personalized prophylaxis”. The ongoing NuPreviq study has enrolled 68 adult patients. Preliminary data in 24 patients indicate a median dosing interval of 3.5 days with 66.7% of patients on a twice-per-week or less infusion schedule with Human-cl rhFVIII. The potential prolonged dosing interval is without increased FVIII consumption when compared to standard prophylaxis. So far, no bleeding episodes have been reported in these 24 patients.
About Haemophilia A
Haemophilia A is an X-linked hereditary disorder caused by factor VIII (FVIII) deficiency which if left untreated leads to haemorrhages in muscles and joints and consequently to arthropathy and severe morbidity. FVIII replacement prophylactic treatment reduces the number of bleeding episodes and the risk of permanent joint damage. This disorder affects one in every 5,000 to 10,000 men worldwide. Globally, 75% of haemophilia cases are left undiagnosed or untreated. The development of neutralising FVIII antibodies (FVIII inhibitors) against infused FVIII represents the most serious treatment complication. The cumulative risk of FVIII inhibitor development is reported to be currently up to 38%.
About Octapharma AG
Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 30 years. Its core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the following therapeutic areas:
Haematology (coagulation disorders)
Immunotherapy (immune disorders)
Critical Care
Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.
For more information visit www.octapharma.com
Contacts
Octapharma AG
Corporate Communications
Claudie Qumsieh
Tel.: +(41)-55-451-21-78
claudie.qumsieh@octapharma.com
Permalink: http://me-newswire.net/news/11109/en
Posted by
Business Daily Africa
Tuesday, May 27, 2014
Edwards Launches New Range of Single Stage Oil Sealed Rotary Vane Vacuum Pumps
CRAWLEY, England. - Tuesday, May 27th 2014 [ME NewsWire]
(BUSINESS WIRE) Edwards’ newly launched range of single stage oil sealed rotary vane pumps is a flexible vacuum solution providing highly stable vacuum performance. Thanks to the optimised oil return system, there are none of the pressure fluctuations that are often seen in single stage pumps improving product quality and giving consistent process results.
The pump mechanism on the new ES pump has been refined to produce a better quality of vacuum; the pumping speed is maintained even at lower pressure, extending the operating pressure range. The new pump has been developed to run cooler and have a longer oil lifetime than other comparable oil sealed vacuum pumps, bringing a low cost of ownership. The in-built oil mist filter ensures minimal oil emission, making the ES environmentally friendly. The ES also has the added benefit of running more quietly than most comparable single stage rotary vane pumps.
For convenience and ease of integration, the ES pump features in-built ISO and BSP connections; it is simple to maintain with easy oil and filter changes and it can be serviced on site by the user, bringing higher productivity.
The new ES pump is designed to be used in a wide range of industrial applications, including heat treatment and coating. There are five variants in the range to suit different requirements, ES65, ES100, ES200, ES300 and ES630. These can be used individually or with the EH range of mechanical booster pumps (variants available from EH250 to EH4200) to increase both performance and ultimate vacuum.
Megha Ajmal, Product Manager at Edwards, commented, “We are proud to be introducing the ES pump range which provides class leading ultimate vacuum levels. Suitable for a wide range of industrial applications and coupled with our robust EH mechanical boosters, it can provide customized solutions to a variety of processes.”
Further information about the ES range can be found at www.edwardsvacuum.com/ES
About Edwards
Edwards is a leading developer and manufacturer of sophisticated vacuum products, abatement systems and related value-added services. These are integral to manufacturing processes for semiconductors, flat panel displays, LEDs and solar cells; are used within an increasingly diverse range of industrial processes including power, glass and other coating applications, steel and other metallurgy, pharmaceutical and chemical; and for both scientific instruments and a wide range of R&D applications.
Edwards has over 3,200 full-time employees and 500 temporary workers operating in approximately 20 countries worldwide engaged in the design, manufacture and support of high technology vacuum and exhaust management equipment.
Further information about Edwards can be found at www.edwardsvacuum.com.
Contacts
Company Contact:
Rebecca Walder
+44 (0) 1293 603103
Rebecca.Walder@edwardsvacuum.com
Permalink: http://me-newswire.net/news/11105/en
(BUSINESS WIRE) Edwards’ newly launched range of single stage oil sealed rotary vane pumps is a flexible vacuum solution providing highly stable vacuum performance. Thanks to the optimised oil return system, there are none of the pressure fluctuations that are often seen in single stage pumps improving product quality and giving consistent process results.
The pump mechanism on the new ES pump has been refined to produce a better quality of vacuum; the pumping speed is maintained even at lower pressure, extending the operating pressure range. The new pump has been developed to run cooler and have a longer oil lifetime than other comparable oil sealed vacuum pumps, bringing a low cost of ownership. The in-built oil mist filter ensures minimal oil emission, making the ES environmentally friendly. The ES also has the added benefit of running more quietly than most comparable single stage rotary vane pumps.
For convenience and ease of integration, the ES pump features in-built ISO and BSP connections; it is simple to maintain with easy oil and filter changes and it can be serviced on site by the user, bringing higher productivity.
The new ES pump is designed to be used in a wide range of industrial applications, including heat treatment and coating. There are five variants in the range to suit different requirements, ES65, ES100, ES200, ES300 and ES630. These can be used individually or with the EH range of mechanical booster pumps (variants available from EH250 to EH4200) to increase both performance and ultimate vacuum.
Megha Ajmal, Product Manager at Edwards, commented, “We are proud to be introducing the ES pump range which provides class leading ultimate vacuum levels. Suitable for a wide range of industrial applications and coupled with our robust EH mechanical boosters, it can provide customized solutions to a variety of processes.”
Further information about the ES range can be found at www.edwardsvacuum.com/ES
About Edwards
Edwards is a leading developer and manufacturer of sophisticated vacuum products, abatement systems and related value-added services. These are integral to manufacturing processes for semiconductors, flat panel displays, LEDs and solar cells; are used within an increasingly diverse range of industrial processes including power, glass and other coating applications, steel and other metallurgy, pharmaceutical and chemical; and for both scientific instruments and a wide range of R&D applications.
Edwards has over 3,200 full-time employees and 500 temporary workers operating in approximately 20 countries worldwide engaged in the design, manufacture and support of high technology vacuum and exhaust management equipment.
Further information about Edwards can be found at www.edwardsvacuum.com.
Contacts
Company Contact:
Rebecca Walder
+44 (0) 1293 603103
Rebecca.Walder@edwardsvacuum.com
Permalink: http://me-newswire.net/news/11105/en
Posted by
Business Daily Africa
Security Support and SCO19 Discuss Ways to Boost Cooperation in Britain
ME NewsWire
ABU DHABI, United Arab Emirates - Monday, May 26th 2014
Abu Dhabi Police, represented by the Security Support Section, discussed ways to enhance cooperation in areas of mutual interest with Metropolitan Police.
Lieutenant Colonel Khaled Saeed Al Shamesi, Chief of Security Support Section at Abu Dhabi Police General Headquarters and the accompanying delegation, met with Commander Neil Basu, Head of Armed Policing in London. During the meeting, which was attended by officials from the Specialist Crime and Operations Specialist Firearms Command (SCO19), the UAE delegation reviewed the various tasks carried out by the unit and its valuable role in combating crime.
Furthermore, both parties tackled ways to strengthen relations and boost joint cooperation and coordination, particularly in training and exchange of expertise in law-related work areas. The Abu Dhabi Police delegation gave a presentation about the Security Support section’s experience and its goals, in line with the higher leadership’s directives to build a distinguished human police cadre, capable of adding value to the security process.
Lieutenant Colonel Al Shamesi elaborated on the role of Security Support Section in managing highly efficient and well-equipped police patrols, led by highly qualified and trained competent officers who have the ability to handle all sorts of incidents according to the laws and regulations applicable in the UAE. He also gave a briefing about the distinguished vision of the Security Support Section, which stems from the Abu Dhabi Police General Headquarters’ strategy, and its keenness to suggest initiatives, respect human values and provide security and stability in the UAE.
Lieutenant Colonel Al Shamesi added that the visit personifies the Abu Dhabi Police General Headquarters’ commitment to strengthen mutual cooperation in police work with Metropolitan Police in London.
The Security Support Section delegation’s visit, which lasted several days, aimed at increasing cooperation and ensuring its continuity. As part of the visit, the delegation toured the Operations Unit at the British Police and inspected the various weapons, technologies and equipment used by the unit. The delegation also watched a presentation that showcased the mechanisms and strategies adopted by the unit to provide protection and security for the 2012 Summer Olympics. The presentation also shed light on the plans, implementation mechanisms and procedures adopted following any kind of accident. The delegation also visited the Metropolitan Police Specialist Training Centre “MPSTC”, and was acquainted with the qualification and training follow-up courses at SCO19 Unit, and scenarios setting to handle all sorts of situations.
Lieutenant Colonel Al Shamesi explained that the visit has achieved its goals by allowing the delegation members to benefit from presentations on a number of situations previously handled by the unit. They also attended a briefing by SCO19 field officers prior to going out on field patrols. Towards the end of the visit, commemorative shields and gifts were exchanged between both parties.
The Metropolitan Police officials praised the distinguished prestigious position attained by the UAE Ministry of Interior and the valuable role of Abu Dhabi Police General Headquarters in promoting security and providing modern services based on international best standards. They also commended its excellence, professionalism and success in combating transnational crimes.
The UAE delegation was headed by Lieutenant Colonel Khaled Saeed Al Shamesi, Chief of Security Support Section and included Major Mohammed Mubarak Al Masa’bi, Security Intervention Patrols Branch Manager; First Lieutenant Bader Mohammed Al Riyami; First Lieutenant Saud Saif Al Zaabi; Warrant Officer Ismail Ali Al Hosani; Legal Consultant Abu Bakr Abdullah Abdul Wahhab; and Operations Specialist Neil John Sharman.
It is worth mentioning that the SCO19 Unit’s tasks are closely similar to the tasks carried out by the Security Support Section, in terms of undertaking unconventional security missions and providing armed support to field police units. This would enhance public safety for the public as well as for police and security personnel.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Permalink: http://www.me-newswire.net/news/11097/en
ABU DHABI, United Arab Emirates - Monday, May 26th 2014
Abu Dhabi Police, represented by the Security Support Section, discussed ways to enhance cooperation in areas of mutual interest with Metropolitan Police.
Lieutenant Colonel Khaled Saeed Al Shamesi, Chief of Security Support Section at Abu Dhabi Police General Headquarters and the accompanying delegation, met with Commander Neil Basu, Head of Armed Policing in London. During the meeting, which was attended by officials from the Specialist Crime and Operations Specialist Firearms Command (SCO19), the UAE delegation reviewed the various tasks carried out by the unit and its valuable role in combating crime.
Furthermore, both parties tackled ways to strengthen relations and boost joint cooperation and coordination, particularly in training and exchange of expertise in law-related work areas. The Abu Dhabi Police delegation gave a presentation about the Security Support section’s experience and its goals, in line with the higher leadership’s directives to build a distinguished human police cadre, capable of adding value to the security process.
Lieutenant Colonel Al Shamesi elaborated on the role of Security Support Section in managing highly efficient and well-equipped police patrols, led by highly qualified and trained competent officers who have the ability to handle all sorts of incidents according to the laws and regulations applicable in the UAE. He also gave a briefing about the distinguished vision of the Security Support Section, which stems from the Abu Dhabi Police General Headquarters’ strategy, and its keenness to suggest initiatives, respect human values and provide security and stability in the UAE.
Lieutenant Colonel Al Shamesi added that the visit personifies the Abu Dhabi Police General Headquarters’ commitment to strengthen mutual cooperation in police work with Metropolitan Police in London.
The Security Support Section delegation’s visit, which lasted several days, aimed at increasing cooperation and ensuring its continuity. As part of the visit, the delegation toured the Operations Unit at the British Police and inspected the various weapons, technologies and equipment used by the unit. The delegation also watched a presentation that showcased the mechanisms and strategies adopted by the unit to provide protection and security for the 2012 Summer Olympics. The presentation also shed light on the plans, implementation mechanisms and procedures adopted following any kind of accident. The delegation also visited the Metropolitan Police Specialist Training Centre “MPSTC”, and was acquainted with the qualification and training follow-up courses at SCO19 Unit, and scenarios setting to handle all sorts of situations.
Lieutenant Colonel Al Shamesi explained that the visit has achieved its goals by allowing the delegation members to benefit from presentations on a number of situations previously handled by the unit. They also attended a briefing by SCO19 field officers prior to going out on field patrols. Towards the end of the visit, commemorative shields and gifts were exchanged between both parties.
The Metropolitan Police officials praised the distinguished prestigious position attained by the UAE Ministry of Interior and the valuable role of Abu Dhabi Police General Headquarters in promoting security and providing modern services based on international best standards. They also commended its excellence, professionalism and success in combating transnational crimes.
The UAE delegation was headed by Lieutenant Colonel Khaled Saeed Al Shamesi, Chief of Security Support Section and included Major Mohammed Mubarak Al Masa’bi, Security Intervention Patrols Branch Manager; First Lieutenant Bader Mohammed Al Riyami; First Lieutenant Saud Saif Al Zaabi; Warrant Officer Ismail Ali Al Hosani; Legal Consultant Abu Bakr Abdullah Abdul Wahhab; and Operations Specialist Neil John Sharman.
It is worth mentioning that the SCO19 Unit’s tasks are closely similar to the tasks carried out by the Security Support Section, in terms of undertaking unconventional security missions and providing armed support to field police units. This would enhance public safety for the public as well as for police and security personnel.
For more information about:
The Ministry of Interior, please click HERE
Abu Dhabi Police, please click HERE
Follow us and check our Social Media feeds on: YouTube, Facebook and Twitter
The Arabic-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the Arabic-language text, which is the only version of the text intended to have legal effect.
Contacts
The UAE Minister of Interior's General Secretariat, Tactical Affairs and Security Media Department
Abu Dhabi Police GHQ - Security Media
Chris Cron +971-(0)-50-987-1317
E-mail: cron.media@hotmail.com
Permalink: http://www.me-newswire.net/news/11097/en
Posted by
Business Daily Africa
UEFA Champions Festival in Lisbon Draws to a Close with Impressive Figures
ME Newswire / Businesswire
LISBON, Portugal. - Monday, May 26th 2014
The 2014 edition of the UEFA Champions Festival closed yesterday following four days of free football-related activities.
Tens of thousands of fans flocked to the festival in Praça do Comercio, Lisbon’s historic square. Highlights included the world premiere of the UEFA Champions League film, a stunning performance by Orquestra Geração and the Ultimate Champions Match, when a side featuring Portuguese and Brazilian legends came up against the UEFA All-Stars team.
23-year-old David Pereira from Lisbon won a UEFA.com competition to join the UEFA All-Stars lineup as a goalkeeper. Fans had previously been invited to send in short video clips, with Vítor Baía and Peter Schmeichel deciding who would be the best choice to don a pair of gloves for the game.
The major attractions at the festival site proved to be the UEFA Champions League and UEFA Women’s Champions League trophies. The two pieces of silverware were brought to Praça do Comercio by an 80-man military band playing the UEFA Champions League anthem, during the festival opening on Thursday 22 May. Over the four days, thousands of fans queued up to have their picture taken with the trophies of the most iconic competitions in world club football.
A number of former players acting as UEFA ambassadors also attended the festival, taking part in skills clinics with young players, signing autographs for fans, replying to fans’ questions on UEFA Facebook Q&A sessions, and engaging in UEFA Champions League sponsor activities. Among them were Steve McManaman, Pedrag Mijatovic, Christian Karembeu, Cafu, Nani, Deco, Rúben Amorim and Youri Djorkaeff.
Earlier in the week, and with former UEFA Champions League winner Maniche in attendance, UEFA presented a new maxi-pitch to the city of Lisbon, to be used by the local community for grassroots football activities.
The UEFA Champions Festival takes place in the host city of the UEFA Champions League and UEFA Women’s Champions League finals. The first edition was held in Paris in 2006. More information on www.uefa.com
Contacts
UEFA
Press contact:
Francisco Empis, Tel: +351913089871
fe@cunhavaz.com
Permalink: http://me-newswire.net/news/11101/en
LISBON, Portugal. - Monday, May 26th 2014
The 2014 edition of the UEFA Champions Festival closed yesterday following four days of free football-related activities.
Tens of thousands of fans flocked to the festival in Praça do Comercio, Lisbon’s historic square. Highlights included the world premiere of the UEFA Champions League film, a stunning performance by Orquestra Geração and the Ultimate Champions Match, when a side featuring Portuguese and Brazilian legends came up against the UEFA All-Stars team.
23-year-old David Pereira from Lisbon won a UEFA.com competition to join the UEFA All-Stars lineup as a goalkeeper. Fans had previously been invited to send in short video clips, with Vítor Baía and Peter Schmeichel deciding who would be the best choice to don a pair of gloves for the game.
The major attractions at the festival site proved to be the UEFA Champions League and UEFA Women’s Champions League trophies. The two pieces of silverware were brought to Praça do Comercio by an 80-man military band playing the UEFA Champions League anthem, during the festival opening on Thursday 22 May. Over the four days, thousands of fans queued up to have their picture taken with the trophies of the most iconic competitions in world club football.
A number of former players acting as UEFA ambassadors also attended the festival, taking part in skills clinics with young players, signing autographs for fans, replying to fans’ questions on UEFA Facebook Q&A sessions, and engaging in UEFA Champions League sponsor activities. Among them were Steve McManaman, Pedrag Mijatovic, Christian Karembeu, Cafu, Nani, Deco, Rúben Amorim and Youri Djorkaeff.
Earlier in the week, and with former UEFA Champions League winner Maniche in attendance, UEFA presented a new maxi-pitch to the city of Lisbon, to be used by the local community for grassroots football activities.
The UEFA Champions Festival takes place in the host city of the UEFA Champions League and UEFA Women’s Champions League finals. The first edition was held in Paris in 2006. More information on www.uefa.com
Contacts
UEFA
Press contact:
Francisco Empis, Tel: +351913089871
fe@cunhavaz.com
Permalink: http://me-newswire.net/news/11101/en
Posted by
Business Daily Africa
OT and China UnionPay Gather the Main Players of the Chinese Mobile Payment Industry in Shanghai
COLOMBES, France. - Monday, May 26th 2014 [ME NewsWire]
(BUSINESS WIRE) Oberthur Technologies, a world leader in digital security solutions for the mobility space and China UnionPay, the global leading bankcard association today announced they will host a Mobile Payment Summit in Shanghai on 27th May 2014.
During this event, the main players of the Mobile Payment industry (leading OEMs, major banks, service providers) will come together in order to discuss the introduction of state-of-the-art products and solutions enabling an easy deployment of secure contactless payment, with strong authentication.
“We are delighted to host this event with Oberthur Technologies the main objective of which is to promote the mobile payment ecosystem with strong authentication and practical innovation. Organizing such an event demonstrates the Chinese ecosystem’s readiness for these innovative technologies which make end-users’ life more convenient and secure ” said Ms HU Ying, Associated VP of CUP.
“For OT, as a leader in mobile payments in the Great China region, it was only natural to partner with CUP in the organization of this event” said Mr Didier Lamouche, President and CEO of OT. “Gathering together the main stakeholders in China is a great opportunity for us to discuss this strategic market and promote adoption of mobile payments”.
ABOUT OBERTHUR TECHNOLOGIES
OT is a world leader in digital security solutions for the mobility space. OT has always been at the heart of mobility, from the first smart cards to the latest contactless payment technologies which equip millions of smartphones. Present in the Payment, Telecommunications and Identity markets, OT offers end-to-end solutions in the Smart Transactions, Mobile Financial Services, Machine-to-Machine, Digital Identity and Transport & Access Control fields. OT employs over 6 000 employees worldwide, including 600 R&D people. With more than 50 sales offices across 5 continents and 10 facilities, OT’s international network serves clients in 140 countries. For more information: www.oberthur.com
Contacts
MEDIA CONTACTS
Oberthur Technologies
Audrey Besnardeau, Tel : +33 1 78 14 76 75
a.besnardeau@oberthur.com
FTI Consulting Strategic Communication
Yannick Duvergé, Tel : +33 1 47 03 68 65 / +33 6 74 91 48 05
yannick.duverge@fticonsulting.com
Permalink: http://www.me-newswire.net/news/11099/en
(BUSINESS WIRE) Oberthur Technologies, a world leader in digital security solutions for the mobility space and China UnionPay, the global leading bankcard association today announced they will host a Mobile Payment Summit in Shanghai on 27th May 2014.
During this event, the main players of the Mobile Payment industry (leading OEMs, major banks, service providers) will come together in order to discuss the introduction of state-of-the-art products and solutions enabling an easy deployment of secure contactless payment, with strong authentication.
“We are delighted to host this event with Oberthur Technologies the main objective of which is to promote the mobile payment ecosystem with strong authentication and practical innovation. Organizing such an event demonstrates the Chinese ecosystem’s readiness for these innovative technologies which make end-users’ life more convenient and secure ” said Ms HU Ying, Associated VP of CUP.
“For OT, as a leader in mobile payments in the Great China region, it was only natural to partner with CUP in the organization of this event” said Mr Didier Lamouche, President and CEO of OT. “Gathering together the main stakeholders in China is a great opportunity for us to discuss this strategic market and promote adoption of mobile payments”.
ABOUT OBERTHUR TECHNOLOGIES
OT is a world leader in digital security solutions for the mobility space. OT has always been at the heart of mobility, from the first smart cards to the latest contactless payment technologies which equip millions of smartphones. Present in the Payment, Telecommunications and Identity markets, OT offers end-to-end solutions in the Smart Transactions, Mobile Financial Services, Machine-to-Machine, Digital Identity and Transport & Access Control fields. OT employs over 6 000 employees worldwide, including 600 R&D people. With more than 50 sales offices across 5 continents and 10 facilities, OT’s international network serves clients in 140 countries. For more information: www.oberthur.com
Contacts
MEDIA CONTACTS
Oberthur Technologies
Audrey Besnardeau, Tel : +33 1 78 14 76 75
a.besnardeau@oberthur.com
FTI Consulting Strategic Communication
Yannick Duvergé, Tel : +33 1 47 03 68 65 / +33 6 74 91 48 05
yannick.duverge@fticonsulting.com
Permalink: http://www.me-newswire.net/news/11099/en
Posted by
Business Daily Africa
Subscribe to:
Posts (Atom)